Theodorus has contributed to a $23.8m series A round for NeuVasQ, the neurological disease drug developer spun out of Université libre de Bruxelles.

The application management platform developer boosted its overall funding to $86m in a round which included Emory University.

With co-founders from Stanford University and National University of Singapore, Nuevocor aims to develop gene therapies for cardiomyopathies.

UTokyo IPC has contributed to a funding round for Telexistence that brought the remote-controlled robotics technology developer’s total funding to $41m.

Uniseed has returned for the latest round raised by Melbourne spinout ENA Respiratory, which is working on a nasal spray to prevent covid-19.

Cambridge Innovation Capital has doubled down on its commitment to Origami, having already taken part in all previous rounds.

Keio spinout Heartseed has added $37m to its coffers thanks to the university's Innovation Initiative and UTokyo Innovation Platform.

ETH Zurich spinout Nexxiot has added $25m to its coffers thanks to a round led by QVIDTVM.

Stanford has contributed to a $26m series A for Jeeves, which was announced concurrently with a $5m seed round and $100m in debt financing.

Bascom Palmer Eye Institute’s spinout is working on AR/VR vision diagnosis and augmentation technology and has secured more cash five months after its seed funding.